United Therapeutics Corp. (UTHR)
498.48
-1.87
(-0.37%)
USD |
NASDAQ |
Sep 16, 16:00
499.56
+1.08
(+0.22%)
After-Hours: 20:00
United Therapeutics Price : 498.48 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 500.62 | 505.78 | 497.66 | 498.48 | 488401.0 |
| Sep 15, 2026 | 505.44 | 507.15 | 498.85 | 500.35 | 1.605M |
| Sep 14, 2026 | 506.78 | 509.06 | 499.62 | 502.70 | 605734.0 |
| Sep 11, 2026 | 505.60 | 508.68 | 496.18 | 497.11 | 573361.0 |
| Sep 10, 2026 | 502.44 | 509.79 | 497.91 | 503.86 | 653160.0 |
| Sep 09, 2026 | 502.75 | 509.52 | 492.90 | 506.82 | 500106.0 |
| Sep 08, 2026 | 494.74 | 505.00 | 479.71 | 497.97 | 643544.0 |
| Sep 04, 2026 | 484.33 | 494.08 | 484.33 | 487.61 | 327025.0 |
| Sep 03, 2026 | 494.09 | 494.09 | 477.06 | 490.24 | 469577.0 |
| Sep 02, 2026 | 510.00 | 510.05 | 477.01 | 492.02 | 1.404M |
| Sep 01, 2026 | 514.20 | 517.75 | 510.39 | 512.70 | 478996.0 |
| Aug 31, 2026 | 510.95 | 515.55 | 507.03 | 510.38 | 538523.0 |
| Aug 28, 2026 | 527.94 | 530.50 | 513.72 | 515.46 | 266870.0 |
| Aug 27, 2026 | 513.98 | 531.76 | 511.00 | 527.91 | 391006.0 |
| Aug 26, 2026 | 515.60 | 522.02 | 513.98 | 516.68 | 254780.0 |
| Aug 25, 2026 | 516.07 | 520.66 | 515.54 | 518.53 | 876497.0 |
| Aug 24, 2026 | 513.12 | 514.30 | 508.15 | 512.88 | 323887.0 |
| Aug 21, 2026 | 523.23 | 528.02 | 512.29 | 513.12 | 415574.0 |
| Aug 20, 2026 | 524.15 | 529.26 | 517.88 | 521.00 | 440385.0 |
| Aug 19, 2026 | 525.47 | 535.77 | 522.04 | 529.14 | 432111.0 |
| Aug 18, 2026 | 510.42 | 519.21 | 508.56 | 518.27 | 366432.0 |
| Aug 17, 2026 | 502.29 | 509.54 | 499.96 | 508.48 | 457341.0 |
| Aug 14, 2026 | 498.91 | 501.62 | 494.34 | 499.73 | 472955.0 |
| Aug 13, 2026 | 515.62 | 515.62 | 499.19 | 501.27 | 408060.0 |
| Aug 12, 2026 | 510.44 | 521.43 | 506.01 | 511.72 | 326126.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 68.45 |
| MannKind Corp. | 3.55 |
| Vertex Pharmaceuticals, Inc. | 513.26 |
| Alnylam Pharmaceuticals, Inc. | 239.36 |
| Savara, Inc. | 5.13 |
Price Related Metrics
| PE Ratio | 17.83 |
| PS Ratio | 7.411 |
| PEG Ratio | 1.946 |
| Price to Book Value | 3.324 |
| Price to Free Cash Flow | 21.57 |
| Earnings Yield | 5.61% |
| Market Cap | 21.27B |
| PEGY Ratio | 1.946 |
| Operating PE Ratio | 16.66 |
| Normalized PE Ratio | 19.11 |